Market Tracker

05/25 5:16pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

20.57
Delayed Data
As of 4:00pm ET
 +0.04 / +0.19%
Today’s Change
11.54
Today|||52-Week Range
42.25
-22.96%
Year-to-Date
Here's Why Trevena Stock Dropped 18% Today
May 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close20.53
Today’s open20.74
Day’s range20.15 - 21.09
Volume407,359
Average volume (3 months)700,858
Market cap$752.6M
Dividend yield--
Data as of 4:00pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)-2.79%
Earnings growth (this year)-16.84%
Earnings growth (next 5 years)+54.07%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.28

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...-0.40-0.81%
INSMInsmed Inc+0.15+1.27%
CPXXCelator Pharmaceutic...+0.44+2.57%
ADROAduro Biotech Inc+0.09+0.82%
Data as of 4:00pm ET, 05/25/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$0.00
Annual profit (last year)-$97.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts